New Delhi: Hi ku hlamula eka xiringanyeto xa Fresenius Medical Care, Komiti ya Vativi vo Hlawuleka (SEC) ya Nhlangano wa Vulawuri bya Mpimo wa Mirhi wa le Xikarhi (CDSCO) yi ringanyete khamphani ku yisa xivangelo xa mpfumelelo xikan’we na datha ya xiyenge xa ​​III xa swikambelo swa tliliniki swa calcium chloride dihydrate na datha ya vuleteri bya le ndzhaku ka ku xavisiwa ku suka ematikweni lama pfumeleriweke ku ya emahlweni yi tekeriwa enhlokweni.
Khampani leyi yi tshame yi endla xikombelo xo endla ni ku xavisa xitofu xa calcium chloride dihydrate hi mpimo wa 100 mmol/L, lexi tirhisiwaka eka “vutshunguri byo cinca khalsiyamu eka vutshunguri lebyi yaka emahlweni byo cinca tinso (CRRT), dialysis leyi yaka emahlweni leyi nga tirhiki kahle (siku na siku) (CLED) ni ku cincana ka plasma hi vutshunguri (TPE) hi citrate anticoagulation.Xiendliwa lexi xi faneleka eka vanhu lavakulu ni vana” naswona u boxe swivangelo swo hlongoriwa eka swikambelo swa tliliniki swa xiyenge xa ​​III na xiyenge xa ​​IV.
Komiti yi xiyile leswaku xiendliwa lexi xi amukeriwile ematikweni ya le Yuropa yo fana na Portugal, United Kingdom, Brazil, Switzerland, Furwa na Denmark.
Nkatsakanyo wa calcium chloride dihydrate i CaCl2 2H2O, leyi nga calcium chloride leyi nga na ti molecule timbirhi ta mati hi yuniti ya calcium chloride. I nchumu wo basa wa crystalline, lowu khulukaka hiku olova ematini naswona wuva na hygroscopic, i.e. wukota ku tswonga ndzhongho kusuka emoyeni.
Calcium chloride dihydrate i compound leyinga tirhisiwaka tani hi solvent system kuva yi n’okisela chitin loko yi pfanganisiwa na methanol. Yi tlanga xiave xa nkoka eka ku tshoveka ka xivumbeko xa crystal xa chitin naswona yina switirhisiwa swotala eka xiyenge xa ​​tikhemikhali.
Eka nhlengeletano ya SEC Nephrology leyi khomiweke hi May 20, 2025, phanele yi kambisisile xiringanyeto xo pfumelela ku endliwa na ku xavisiwa ka 100 mmol/L calcium chloride dihydrate infusion solution ku tirhisiwa eka “vutshunguri byo siva khalsiyamu eka vutshunguri byo cinca tinso lebyi yaka emahlweni (CRRT), dialysis leyi yaka emahlweni ya vukorhokeri bya le hansi (siku na siku) (SLEDD), na ku cincana ka plasma loku yaka emahlweni (TPE) na citrate anticoagulation Xiendliwa xi kombisiwile eka vanhu lavakulu na vana” naswona xi nyikile xivangelo xa ku ntshunxiwa eka swikambelo swa tliliniki swa xiyenge xa ​​III na IV.
Endzhaku ka mbulavurisano wa vuxokoxoko, komiti yi ringanyete leswaku xisekelo xa mpfumelelo, xikan’we na datha ya xiyenge xa ​​III xa swikambelo swa tliliniki na datha ya vuleteri bya le ndzhaku ka ku xavisiwa ku suka eka matiko lama pfumeleleke murhi, swi yisiwa eka komiti leswaku yi ya emahlweni yi langutiwa.
Hlaya nakambe: Ntlawa wa CDSCO wu Pfumelela Ku Lebula loku Pfuxetiweke ka Myozyme ya Sanofi, Wu Kombela Nkambisiso wa Nawu
Dokodela Divya Kolin i mudyondzisi wa PharmD loyi a nga na ntokoto wo anama wa tliliniki na le xibedlhele na vuswikoti bya kahle byo kambela na vutshunguri. U tlhele a tirha tanihi muendli wa tikhemisi wa oncology eka ndzawulo ya oncology eMysore Medical College and Research Institute. Sweswi u le ku landzeleleni ka ntirho wa yena eka ndzavisiso wa tliliniki na vufambisi bya datha ya tliliniki. U tirhile na Medical Dialogue ku sukela hi Ndzhati 2022.
       Dr Kamal Kant Kohli, MBBS, MD, CP, is a thoracic specialist with over 30 years of experience and specializes in clinical writing. He joins Medical Dialogues as the Editor-in-Chief of Medical News. Apart from writing articles, as the Editor, he is responsible for proofreading and reviewing all medical content published in Medical Dialogues, including content from journals, research papers, medical conferences, guidelines, etc. Email: drkohli@medicaldialogues.in Contact: 011-43720751
Nkambisiso wa ABYSS wu kumile leswaku ku yimisa ti beta-blockers endzhaku ka myocardial infarction swi endle leswaku ku tlakuka ka nsusumeto wa ngati, ku ba ka mbilu, na swiendlakalo swo biha swa mbilu na misiha: ...